Remicade

March 19, 2015March 19, 2015

Samsung Submits MAA for Remicade Biosimilar For Crohn’s Disease, Ulcerative Colitis to EMA

Crohn's Disease, News, Ulcerative colitis

Samsung Bioepis Co. Ltd. recently submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) regarding a biosimilar treatment for several conditions, including Crohn’s disease and ulcerative colitis. The Remicade (Infliximab) ... Read more

February 26, 2015September 28, 2016

Hospira Presents Updates on Biosimilar Inflectra for IBD at 2015 ECCO-IBD Conference

News

Recently, IBD News Today reported on how Hospira, Inc. announced the launch of Inflectra (infliximab), the first biosimilar monoclonal antibody (mAb), in major European markets. Now, the company has been invited ... Read more

February 24, 2015February 24, 2015

Hospira Launches First Biosimilar Monoclonal Antibody for Adult & Pediatric Crohn’s, Ulcerative Colitis In Europe

News, Ulcerative colitis

Hospira, Inc., a biotechnology company developing biosimilar therapies, has recently announced the launch of Inflectra (infliximab), the first biosimilar monoclonal antibody (mAb), in major European markets. Inflectra is licensed to address several inflammatory conditions such as rheumatoid arthritis, ... Read more

December 16, 2014December 16, 2014

UK Patients with Moderately to Severely Active UC Gain Access to New Drugs

News, Ulcerative colitis

Patients with moderately to severely active ulcerative colitis, residing in the United Kingdom, now have access to several new drugs thanks to the Final Appraisal Document (FAD) from the National Institute ... Read more

December 5, 2014September 28, 2016

First Biosimilar Of Infliximab Drug In India Was Launched By Ranbaxy Laboratories Ltd

News

Infimab, the first Remicade (Infliximab) biosimilar revealed to be successful in treating inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn’s Disease, ulcerative colitis, psoriasis and psoriatic arthritis, was recently launched ... Read more

October 8, 2014October 8, 2014

IBD Patients Respond Well To Restarting Remicade, According To Study

IBD News, News

A new study entitled “Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy” published in the journal Clinical Gastroenterology and Hepatology reports the safety and ... Read more

September 15, 2014September 15, 2014

Infliximab Maintains IBD Remission Longer with Dose Adjustment and Monitoring

IBD News, News

It is estimated that roughly 1.4 million Americans suffer from inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis. Every year, over 30,000 new IBD diagnoses are made, ... Read more